Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Haleon
gptkb:Ciba-Geigy gptkb:GSK_Consumer_Healthcare |
| gptkbp:activities |
COX inhibitor
|
| gptkbp:approves |
gptkb:1988
gptkb:FDA |
| gptkbp:brand |
Voltaren Emulgel
Voltaren Ophtha Voltaren Rapid |
| gptkbp:clinical_trial |
pain management studies
osteoarthritis studies post-operative pain studies rheumatoid arthritis studies treatment of acute pain studies |
| gptkbp:contraindication |
gptkb:healthcare_organization
severe heart failure peptic ulcer |
| gptkbp:dosage_form |
oral
topical injectable |
| gptkbp:formulation |
gptkb:tablet
injection |
| https://www.w3.org/2000/01/rdf-schema#label |
Voltaren
|
| gptkbp:ingredients |
C14 H11 Cl2 N Na O2
diclofenac |
| gptkbp:interacts_with |
gptkb:methotrexate
lithium anticoagulants other NSAI Ds |
| gptkbp:is_available_on |
gptkb:drug
prescription medication |
| gptkbp:is_used_for |
pain relief
inflammation reduction |
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:marketed_as |
many countries
|
| gptkbp:pharmacokinetics |
excreted in urine
highly protein-bound metabolized in liver |
| gptkbp:safety_features |
risk of cardiovascular events
use with caution in elderly patients risk of renal impairment not for use in children under 14 years risk of gastrointestinal ulceration |
| gptkbp:scholarships |
avoid alcohol
take with food not recommended during pregnancy consult doctor for long-term use monitor for gastrointestinal bleeding |
| gptkbp:side_effect |
dizziness
headache nausea stomach pain |
| gptkbp:weight |
318.14 g/mol
|